ORILISSA (elagolix sodium) Abbvie Patent: 7,176,211 Expiration: Jul 6, 2024 See More … For more information on how DrugPatentWatch can […]
Drug Patent Expirations for the Week of June 30, 2024 Read Post »
Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Valinor and is included in one NDA. It
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 23, 2024 Read Post »
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can
Drug Patent Expirations for the Week of June 23, 2024 Read Post »
Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in one NDA.
New patent expiration for Salix Pharms drug XIFAXAN Read Post »
Annual Drug Patent Expirations for TPOXX Tpoxx is a drug marketed by Siga Technologies and is included in two NDAs.
New patent expiration for Siga Technologies drug TPOXX Read Post »
Annual Drug Patent Expirations for NUVIGIL Nuvigil is a drug marketed by Cephalon and is included in one NDA. It
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one
New patent expiration for Otsuka drug ABILIFY MYCITE KIT Read Post »
ABRAXANE (paclitaxel) Bristol-myers Patent: 8,314,156 Expiration: Jun 9, 2024 See More … For more information on how DrugPatentWatch can help
Drug Patent Expirations for the Week of June 9, 2024 Read Post »
Get fresh news and insights, drug patent expirations & more…
